Published in J Endocrinol on August 01, 1994
The OECD program to validate the rat uterotrophic bioassay. Phase 2: dietary phytoestrogen analyses. Environ Health Perspect (2003) 1.30
Cross-species and interassay comparisons of phytoestrogen action. Environ Health Perspect (2001) 1.29
Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic β-cell function. Food Funct (2013) 1.01
Equol production changes over time in pre-menopausal women. Br J Nutr (2011) 0.94
Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer (2004) 0.90
Phytoestrogens in postmenopausal indications: A theoretical perspective. Pharmacogn Rev (2011) 0.89
The effect of flaxseed dose on circulating concentrations of alpha-linolenic acid and secoisolariciresinol diglucoside derived enterolignans in young, healthy adults. Eur J Nutr (2015) 0.75
Excessive levels of diverse phytoestrogens can modulate steroidogenesis and cell migration of KGN human granulosa-derived tumor cells. Toxicol Rep (2014) 0.75
A prognostic index in primary breast cancer. Br J Cancer (1982) 7.35
Regulation: positive control. Annu Rev Genet (1974) 4.34
Diet and overall survival in elderly people. BMJ (1995) 3.73
An improved DNA sequencing strategy. Anal Biochem (1985) 3.22
Regulation of the L-arabinose operon BAD in vitro. J Biol Chem (1974) 2.68
Relationship of oestrogen-receptor status to survival in breast cancer. Lancet (1979) 2.55
DNA sequence of the araBAD promoter in Escherichia coli B/r. Proc Natl Acad Sci U S A (1978) 2.51
Relationship between primary breast tumor receptor status and patient survival. Cancer (1980) 2.49
Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. J Natl Cancer Inst (1995) 2.49
A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods (1994) 2.16
Oestrogen receptors and survival in early breast cancer. Br Med J (Clin Res Ed) (1981) 2.14
Can linoleic acid contribute to coronary artery disease? Am J Clin Nutr (1993) 2.12
Regulation of the araC gene of Escherichia coli: catabolite repression, autoregulation, and effect on araBAD expression. Proc Natl Acad Sci U S A (1984) 2.10
Direction of transcription of the regulatory gene araC in Escherichia coli B-r. Proc Natl Acad Sci U S A (1974) 2.05
The use of synthetic oligodeoxyribonucleotides to produce specific deletions in the araBAD promoter of Escherichia coli B/r. Gene (1982) 1.98
Interaction of the regulatory gene product with the operator site in the L-arabinose operon of Escherichia coli. J Mol Biol (1974) 1.97
Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer (1989) 1.97
Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res (1978) 1.95
A rapid high-yield purification procedure for the cyclic adenosine 3',5'-monophosphate receptor protein from Escherichia coli. Biochim Biophys Acta (1978) 1.93
In vitro activation of the transcription of araBAD operon by araC activator. Proc Natl Acad Sci U S A (1974) 1.91
Relationship between oestrogen-receptor content and histological grade in human primary breast tumours. Br J Cancer (1978) 1.90
Telephone directory listings of presumptive Chinese surnames: an appropriate sampling frame for a dispersed population with characteristic surnames. Epidemiology (1990) 1.88
Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma. Br J Urol (1991) 1.83
Oestrogen receptors and prognosis in early breast cancer. Lancet (1979) 1.83
Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pac J Clin Nutr (1994) 1.80
The araIc mutation in Escherichia coli B/r. J Bacteriol (1981) 1.73
Isolation of ara-lac gene fusions in Salmonella typhimurium LT2 by using transducing bacteriophage Mu d (Apr lac). J Bacteriol (1980) 1.72
Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer (1996) 1.71
Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol (1985) 1.67
Deoxyribonucleic acid sequence of araBAD promoter mutants of Escherichia coli. J Bacteriol (1980) 1.66
DNA sequence of the araC regulatory gene from Escherichia coli B/r. Nucleic Acids Res (1980) 1.62
Characterization of the Erwinia carotovora pelB gene and its product pectate lyase. J Bacteriol (1987) 1.57
Clinical review 92: Phytoestrogens. J Clin Endocrinol Metab (1998) 1.55
Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis. Gastroenterology (1993) 1.52
A microprocedure for the measurement of 14CO2 release from [14C]carboxyl-labeled amino acids. Anal Biochem (1978) 1.50
Cloning of the pectate lyase genes from Erwinia carotovora and their expression in Escherichia coli. Gene (1985) 1.49
Visualization of ventricular fibroelastoma with a video-assisted thoracoscope. Ann Thorac Surg (1997) 1.49
Phytoestrogens and breast cancer in postmenopausal women: a case control study. Menopause (2000) 1.49
Deoxyribonucleic acid-ribonucleic acid hybridization studies on the L-Arabinose operon of Escherichia coli B-r. J Bacteriol (1971) 1.48
Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinoma. Lancet (1983) 1.47
Debendox and congenital malformations in Northern Ireland. Br Med J (1980) 1.46
A randomized controlled trial of penicillin vs clindamycin for the treatment of aspiration pneumonia in children. Arch Pediatr Adolesc Med (1997) 1.43
Inhibition of LDL oxidation by green tea extract. Lancet (1997) 1.41
Prostate-specific antigen: problems in analysis. Eur J Cancer (1991) 1.40
araB Gene and nucleotide sequence of the araC gene of Erwinia carotovora. J Bacteriol (1985) 1.39
Risk factors for coronary heart disease in a self-referred population compared with a general population. Med J Aust (1989) 1.38
Oestrogen-receptor status and sites of metastasis in breast cancer. Br J Cancer (1981) 1.38
Constitutive mutations in the controlling site region of the araBAD operon of Escherichia coli B/r that decrease sensitivity to catabolite repression. J Bacteriol (1977) 1.35
Dietary flour supplementation decreases post-menopausal hot flushes: effect of soy and wheat. Maturitas (1995) 1.33
Metabolism of C19-steroids by foetal cotyledons from the bovine placenta at term. Res Vet Sci (1969) 1.32
Steroid metabolism by human breast tumours. Biochem J (1970) 1.32
Steroid receptors in early breast cancer: value in prognosis. J Steroid Biochem (1981) 1.31
Immunocytochemical localization of estrogen receptor in human breast tissue. Cancer Res (1988) 1.31
Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy. Lancet (1981) 1.29
Are the advantages of the Mediterranean diet transferable to other populations? A cohort study in Melbourne, Australia. Br J Nutr (1999) 1.26
Training in clinical nutrition: undergraduate and postgraduate. Lancet (1983) 1.25
Plasma 17OH-progesterone concentrations in newborn infants. Arch Dis Child (1979) 1.24
Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. Br J Cancer (1987) 1.23
The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions. Eur J Cancer (1979) 1.23
Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong, and the United Kingdom. Prostate (1997) 1.23
Genetic characterization of the araE gene in Salmonella typhimurium lt2. J Bacteriol (1981) 1.22
Identification of talc on surgeons' gloves and in tissue from starch granulomas. Br J Surg (1975) 1.22
Plasma prolactin in breast cancer. Eur J Cancer (1973) 1.22
Ingestion of talc particles by cultured lung fibroblasts. Environ Res (1975) 1.22
Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol (1995) 1.21
The inhibition of deoxyribonucleic acid nucleotidyltransferase by stilboestrol derivatives. Biochem J (1968) 1.20
Internal quality control in clinical chemistry: a teaching review. Stat Med (1987) 1.19
Evidence that polygalacturonase is a virulence determinant in Erwinia carotovora. J Bacteriol (1985) 1.19
Endocrine treatment in prostate cancer. Semin Surg Oncol (2000) 1.18
The araC regulatory gene mRNA contains a leader sequence. Mol Gen Genet (1980) 1.18
A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. J Int Neuropsychol Soc (1997) 1.17
Enhanced peripheral vasodilation in humans after a fatty meal. J Am Coll Cardiol (2000) 1.16
Talc and carcinoma of the ovary and cervix. J Obstet Gynaecol Br Commonw (1971) 1.15
Oestrogenic effects of plant foods in postmenopausal women. BMJ (1990) 1.15
Hybrid plasmids containing the araBAD genes of Escherichia coli B/r. Gene (1978) 1.12
Survival patterns in hormone treated advanced breast cancer. Br J Surg (1986) 1.12
The benefits of a shared-care prostate clinic. Br J Urol (1996) 1.12
Effect of mutations in the cyclic AMP receptor protein-binding site on araBAD and araC expression. J Bacteriol (1989) 1.11
Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy. Acta Endocrinol (Copenh) (1976) 1.10
Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women. J Endocrinol (1976) 1.10
The early results from a randomised study of radiotherapy versus Nolvadex (tamoxifen) as initial treatment for stage III breast cancer. Eur J Surg Oncol (1988) 1.09
The effect of some stilboestrol compounds on DNA polymerase from human prostatic tissue. Steroids (1970) 1.09
Steroids in saliva for assessing endocrine function. Endocr Rev (1982) 1.09
The nucleotide sequence of the araC regulatory gene in Salmonella typhimurium LT2. Gene (1982) 1.08
An objective biochemical assessment of therapeutic response in metastatic breast cancer: a study with external review of clinical data. Br J Cancer (1990) 1.07
Relationship in man between plasma free fatty acids and myocardial metabolism of carbohydrate substrates. Lancet (1971) 1.07
The araBAD operon of Salmonella typhimurium LT2. I. Nucleotide sequence of araB and primary structure of its product, ribulokinase. Gene (1985) 1.06
The araBAD operon of Salmonella typhimurium LT2. II. Nucleotide sequence of araA and primary structure of its product, L-arabinose isomerase. Gene (1985) 1.05
DNA sequence of the araBAD-araC controlling region in Salmonella typhimurium LT2. Gene (1981) 1.05
Effect of araC gene product on catabolite repression in the L-arabinose regulon. J Bacteriol (1976) 1.05
The interaction of L-arabinose and D-fucose with AraC protein. J Biol Chem (1974) 1.05
Pressuring pain. Alternative therapies for labor pain management. AWHONN Lifelines (1997) 1.03
An anti-atherogenic effect of Schistosoma mansoni infections in mice associated with a parasite-induced lowering of blood total cholesterol. Parasitology (2002) 1.02
Diet and its preventive role in prostatic disease. Eur Urol (1999) 1.02
Effects of dietary phytoestrogens in postmenopausal women. Climacteric (1998) 1.02
World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH. Prog Urol (1991) 1.01
Positive control of the L-rhamnose genetic system in Salmonella typhimurium LT2. J Bacteriol (1984) 1.01
Determination of the 11-beta-hydroxylase activity in microgram samples of tissue; its quantitative histological distribution in the rat adrenal, and the influence of corticotrophin. J Endocrinol (1966) 1.01
Purification of the araC protein. Proc Natl Acad Sci U S A (1971) 1.01